The vaccine, known as CoronaVac, is still in phase 3 clinical trials in Brazil and has not been registered for wider use in Brazil, Anvisa said.
Brazil health auth. OKs import of 6 mln doses of Chinese COVID-19 vaccine
By EFRAT FORSHER
01/23/2025 10:02 AM
By REUTERS
01/23/2025 08:50 AM
By REUTERS
01/23/2025 08:46 AM
By REUTERS
01/23/2025 07:10 AM
By REUTERS
01/23/2025 05:58 AM
By REUTERS
01/23/2025 04:09 AM
By REUTERS
01/23/2025 02:32 AM
By REUTERS
01/23/2025 02:29 AM
By REUTERS
01/23/2025 02:28 AM
By REUTERS
01/23/2025 02:21 AM
By REUTERS
01/23/2025 01:58 AM